Concepedia

Dik J. Kwekkeboom

DJ

104

Publications

20.4K

Citations

64

H-Index

1989

Active since

Affiliations

Erasmus MC(Current)

Erasmus University Rotterdam

Rotterdam University of Applied Sciences

Hôpital Beaujon

Zentralklinik Bad Berka

Dik J. Kwekkeboom is an author at Erasmus MC specializing in medicine, pathology, and oncology.

Top concepts

Publications per year

1989–2019

104

Publications

104

Phase 3 Trial of <sup>177</sup> Lu-Dotatate for Midgut Neuroendocrine Tumors

Jonathan Strosberg, Ghassan El‐Haddad, Edward M. Wolin et al. · New England Journal of Medicine · 2017 · 3K citations · Full text

Treatment With the Radiolabeled Somatostatin Analog [ <sup>177</sup> Lu-DOTA <sup>0</sup> ,Tyr <sup>3</sup> ]Octreotate: Toxicity, Efficacy, and Survival

Dik J. Kwekkeboom, Wouter W. de Herder, Boen L.R. Kam et al. · Journal of Clinical Oncology · 2008 · 1.4K citations · Full text

ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors

Massimo Falconi, Barbro Eriksson, Gregory Kaltsas et al. · Neuroendocrinology · 2016 · 1.3K citations · Full text

The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours

John J. Zaknun, Lisa Bodei, Jan Mueller‐Brand et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2013 · 790 citations · Full text

Radiolabeled Somatostatin Analog [<sup>177</sup>Lu-DOTA<sup>0</sup>,Tyr<sup>3</sup>]Octreotate in Patients With Endocrine Gastroenteropancreatic Tumors

Dik J. Kwekkeboom, Jaap J.M. Teunissen, Willem H. Bakker et al. · Journal of Clinical Oncology · 2005 · 657 citations · Full text

Rows per page

1–5 of 104